The US seems behind in its efforts to contain the SARS-CoV-2 epidemic. Learnings from other countries, in particular Italy and Germany, indicate that infections have already spread widely in communities and can no longer be traced and controlled. These countries are ahead of the curve and there is no reason to believe that developments in the US will not follow this same path. Continue Reading
During my meeting with Prof. Dr. Manfred Wildner and his colleague Dr. Herbert Zöllner in Munich, Germany, we discussed the comparative advantages and disadvantages of the German, UK, and US public health systems. The systems are strikingly different.
On the preparedness front in the United States, the new National Biodefense Strategy was released on September 19, 2018. The new strategy establishes clear and thoughtful goals that will become a vital part of “managing the risk of biological incidents… in today’s interconnected world” 1. Continue Reading